PMA-PS1

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NamePMA-PS1

Drug Alias NameMeCP2 replacement therapy (IPT Pharma/PharmedArtis)recombinant methyl CpG binding protein 2 replacement therapy (IPT Pharma/PharmedArtis)IPT-RS1PMA-PS1

ClassificationBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionMethyl-CpG-binding protein 2 stimulantsNeuroprotectants

TargetsMethyl-CpG-binding protein 2

Therapy Area/IndicationsChild Development Disorders, PervasiveRett Syndrome

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermanySwitzerland

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Göttingen

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesIPT-Pharma AG PharmedArtis GmbH University Of Göttingen

Active IndicationsN/A

Inactive IndicationsChild Development Disorders, PervasiveRett Syndrome

Other Information

ATC CodeN/A